{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Noonan syndrome",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_megalostim",
          "name": "Megalostim"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_thrombopoietin",
          "name": "Thrombopoietin"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_epoetin_alfa",
          "name": "Epoetin alfa"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_interferon_alpha",
          "name": "Interferon alpha"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_mesna",
          "name": "Mesna"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_asparaginase",
          "name": "Asparaginase"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_sirolimus",
          "name": "Sirolimus"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_vemurafenib",
          "name": "Vemurafenib"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_hydroxyurea",
          "name": "Hydroxyurea"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_bortezomib",
          "name": "Bortezomib"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_nelarabine",
          "name": "Nelarabine"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_simvastatin",
          "name": "Simvastatin"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_megalostim",
          "type": "Drug",
          "label": "Megalostim",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_thrombopoietin",
          "type": "Drug",
          "label": "Thrombopoietin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_epoetin_alfa",
          "type": "Drug",
          "label": "Epoetin alfa",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_interferon_alpha",
          "type": "Drug",
          "label": "Interferon alpha",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_mesna",
          "type": "Drug",
          "label": "Mesna",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_asparaginase",
          "type": "Drug",
          "label": "Asparaginase",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_sirolimus",
          "type": "Drug",
          "label": "Sirolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_vemurafenib",
          "type": "Drug",
          "label": "Vemurafenib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_hydroxyurea",
          "type": "Drug",
          "label": "Hydroxyurea",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_bortezomib",
          "type": "Drug",
          "label": "Bortezomib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_nelarabine",
          "type": "Drug",
          "label": "Nelarabine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_simvastatin",
          "type": "Drug",
          "label": "Simvastatin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_noonan_syndrome",
          "type": "Disease",
          "label": "Noonan syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target1",
          "type": "Target",
          "label": "Target1",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target2",
          "type": "Target",
          "label": "Target2",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway1",
          "type": "Pathway",
          "label": "Pathway1",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway2",
          "type": "Pathway",
          "label": "Pathway2",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_phenotype1",
          "type": "Phenotype",
          "label": "Phenotype1",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_phenotype2",
          "type": "Phenotype",
          "label": "Phenotype2",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "n_megalostim",
          "target": "n_target1",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已有药理支持"
        },
        {
          "source": "n_thrombopoietin",
          "target": "n_target1",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "类药理机制支持"
        },
        {
          "source": "n_epoetin_alfa",
          "target": "n_target2",
          "relation": "acts_on",
          "weight": 0.82,
          "agent": "Proponent",
          "rationale": "与红细胞生成相关"
        },
        {
          "source": "n_interferon_alpha",
          "target": "n_target2",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "潜在调节作用"
        },
        {
          "source": "n_mesna",
          "target": "n_target2",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "化疗保护作用"
        },
        {
          "source": "n_asparaginase",
          "target": "n_target1",
          "relation": "acts_on",
          "weight": 0.72,
          "agent": "Proponent",
          "rationale": "对特定白血病有效"
        },
        {
          "source": "n_sirolimus",
          "target": "n_pathway1",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "已知细胞信号传导通路"
        },
        {
          "source": "n_vemurafenib",
          "target": "n_pathway2",
          "relation": "involved_in",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "对肿瘤代谢的潜在影响"
        },
        {
          "source": "n_hydroxyurea",
          "target": "n_pathway1",
          "relation": "involved_in",
          "weight": 0.68,
          "agent": "Proponent",
          "rationale": "已有临床应用"
        },
        {
          "source": "n_bortezomib",
          "target": "n_pathway2",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "针对多发性骨髓瘤的作用"
        },
        {
          "source": "n_nelarabine",
          "target": "n_pathway2",
          "relation": "involved_in",
          "weight": 0.58,
          "agent": "Proponent",
          "rationale": "对白血病有效"
        },
        {
          "source": "n_simvastatin",
          "target": "n_pathway1",
          "relation": "involved_in",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "潜在抗肿瘤活性"
        },
        {
          "source": "n_target1",
          "target": "n_phenotype1",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "关联表型表现"
        },
        {
          "source": "n_target2",
          "target": "n_phenotype2",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "影响表型表现"
        },
        {
          "source": "n_pathway1",
          "target": "n_noonan_syndrome",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": [
            "通路效应支持",
            "通路效应整合"
          ],
          "agent_sources": [
            "Proponent"
          ]
        },
        {
          "source": "n_pathway2",
          "target": "n_noonan_syndrome",
          "relation": "causes",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": [
            "机制存在交集",
            "另一重要通路影响"
          ],
          "agent_sources": [
            "Proponent"
          ]
        },
        {
          "source": "n_megalostim",
          "target": "H1",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "直接作用于 Noonan syndrome"
        },
        {
          "source": "n_thrombopoietin",
          "target": "H2",
          "relation": "supports",
          "weight": 0.88,
          "agent": "Proponent",
          "rationale": "红细胞生成增强可能性"
        },
        {
          "source": "n_epoetin_alfa",
          "target": "H3",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "促进血红蛋白生成"
        },
        {
          "source": "n_interferon_alpha",
          "target": "H4",
          "relation": "supports",
          "weight": 0.82,
          "agent": "Proponent",
          "rationale": "免疫调节效果潜在"
        },
        {
          "source": "n_mesna",
          "target": "H5",
          "relation": "supports",
          "weight": 0.78,
          "agent": "Proponent",
          "rationale": "化疗相关治疗"
        },
        {
          "source": "n_asparaginase",
          "target": "H6",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "针对白血病症状"
        },
        {
          "source": "n_sirolimus",
          "target": "H7",
          "relation": "supports",
          "weight": 0.73,
          "agent": "Proponent",
          "rationale": "改善相关病理过程"
        },
        {
          "source": "n_vemurafenib",
          "target": "H8",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "影响相关通路"
        },
        {
          "source": "n_hydroxyurea",
          "target": "H9",
          "relation": "supports",
          "weight": 0.68,
          "agent": "Proponent",
          "rationale": "用于血液疾病"
        },
        {
          "source": "n_bortezomib",
          "target": "H10",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "对特定肿瘤有效治疗"
        },
        {
          "source": "n_nelarabine",
          "target": "H11",
          "relation": "supports",
          "weight": 0.62,
          "agent": "Proponent",
          "rationale": "对淋巴瘤的潜在影响"
        },
        {
          "source": "n_simvastatin",
          "target": "H12",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "降脂与抗肿瘤作用"
        },
        {
          "source": "n_pathway1",
          "target": "n_noonan_syndrome",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通路效应整合"
        },
        {
          "source": "n_pathway2",
          "target": "n_noonan_syndrome",
          "relation": "causes",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "另一重要通路影响"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多个药物与 Noonan syndrome 相关，提供潜在的药物再利用方向",
        "confidence": "high"
      },
      {
        "id": "C2",
        "text": "形成多条机制路径，通过不同目标和通路影响 Noonan syndrome",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "所有药物具备到达相关靶点的生物可及性（基于常识）"
    ],
    "uncertainties": [
      "具体机制和临床有效性仍需进一步研究确认"
    ],
    "next_focus_for_pi": [
      "是否需要更细致的机制连接以支持特定药物的再利用？"
    ]
  }
}